Status:
COMPLETED
Fixed Dose Spinal Bupivacaine for Cesarean Delivery
Lead Sponsor:
Bartosz Horosz, MD
Collaborating Sponsors:
Centre of Postgraduate Medical Education
Conditions:
Spinal Anesthesia
Cesarean Section
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The study is designed to compare the effectiveness of spinal anesthesia performed with fixed dose of hyperbaric bupivacaine regardless of patient's height and weight and anesthesia with the dose of bu...
Eligibility Criteria
Inclusion
- singleton pregnancy above 37Hbd scheduled for elective cesarean section
- ASA 1 or 2
Exclusion
- absolute contraindications to spinal anesthesia
- delivery in progress
- non-singleton pregnancy
- BMI\>35
- ultrasound - based estimation of fetal weight below 10 percentile
- pregnancy-induced hypertension
- more than 2 cesarean sections in patient's medical history
- significantly increased risk of obstetric hemorrhage (placenta previa)
Key Trial Info
Start Date :
July 24 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 3 2019
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT03231436
Start Date
July 24 2017
End Date
June 3 2019
Last Update
June 11 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre of Postgraduate Medical Education,Department of Anesthesia and Intensive Care
Warsaw, Poland, 01-813